SCHEMBL31683333

SCHEMBL31683333

CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)[C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)O

nearest known ligand 0.66

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CALCR P30988 4/20 0.60
F2 P00734 4/20 0.59
OPRD1 P41143 3/20 0.57
OPRM1 P35372 2/20 0.57
OPRK1 P41145 2/20 0.57
CRHR1 P34998 1/20 0.57
CRHR2 Q13324 1/20 0.57
NPY2R P49146 3/20 0.57
NPY4R P50391 3/20 0.57
NPY5R Q15761 3/20 0.57
NPY1R P25929 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31688332 0.92 OPRM1 (0.61) CALCRF2OPRD1OPRM1OPRK1
SCHEMBL29867671 0.91 F2 (0.62) CALCRF2NPY2RNPY4RNPY5R
SCHEMBL31182783 0.91 CALCR (0.63) CALCRF2NPY2RNPY4RNPY5R
SCHEMBL31182439 0.91 CALCR (0.63) CALCRF2OPRD1OPRM1OPRK1
SCHEMBL31603945 0.90 CALCR (0.64) CALCRF2CRHR1CRHR2NPY2R
SCHEMBL31683251 0.90 OPRD1 (0.60) CALCROPRD1OPRM1OPRK1
SCHEMBL30262116 0.90 F2 (0.62) CALCRF2OPRD1NPY2RNPY4R
SCHEMBL30512573 0.90 OPRD1 (0.57) CALCRF2OPRD1CRHR1CRHR2
SCHEMBL31182911 0.89 CALCR (0.65) CALCRF2OPRD1OPRM1OPRK1
SCHEMBL30432005 0.89 CALCR (0.62) CALCRF2CRHR1CRHR2NPY2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250283037-A1 METHODS FOR STIMULATING AND TRANSDUCING T CELLS JUNO THERAPEUTICS GMBH (DE) 2025-09-11 US disclosed